MARKET

AVGR

AVGR

Avinger
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9650
+0.0249
+2.65%
Opening 15:27 07/28 EDT
OPEN
0.9400
PREV CLOSE
0.9401
HIGH
0.9789
LOW
0.9350
VOLUME
780.91K
TURNOVER
--
52 WEEK HIGH
2.670
52 WEEK LOW
0.2139
MARKET CAP
92.01M
P/E (TTM)
-2.4536
1D
5D
1M
3M
1Y
5Y
Avinger to Announce Second Quarter 2021 Results on August 10, 2021
REDWOOD CITY, CA / ACCESSWIRE / July 27, 2021 / Avinger, Inc. (Nasdaq:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PA...
ACCESSWIRE · 23h ago
10 Best One Dollar Stocks to Buy Now
In this article, we will be looking at some of the best stocks currently trading at about $1. If you want to skip our detailed analysis of penny stocks, you can go directly to the 5 Best One Dollar Stocks to Buy Now. Penny stock investing can be a lucrativ...
Insider Monkey · 6d ago
Thinking about buying stock in Nokia, Clovis Oncology, Avinger, Ericsson, or New Oriental Education?
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NOK, CLVS, AVGR, ERIC, and EDU.
PR Newswire - PRF · 07/13 13:31
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers
Benzinga · 07/06 20:31
Avinger Files US Application For New Pantheris In-Stent Restenosis Indication
Benzinga · 07/06 14:26
Avinger stock gains 9% after filing 510(k) application for new Pantheris clinical indication
Avinger (AVGR) jumps 9% premarket after submitting a 510(k) application to the FDA for a new Pantheris clinical indication for the treatment of in-stent restenosis ((ISR)) in the lower extremity arteries.The application is
Seekingalpha · 07/06 13:10
Avinger Announces 510(k) Filing For New Pantheris In-Stent Restenosis Indication
Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today
Benzinga · 07/06 12:36
MongoDB, Sotera Health, Cerevel Therapeutics among premarket losers' pack
Altimmune (ALT) -33% Altimmune to scrap COVID-19 vaccine program after "disappointing" results.Panbela Therapeutics (PBLA) -26% after secures $10M capital raiseMarin Software (MRIN) -20%.Check-Cap (CHEK) -17% after announcing $35M registered direct offerin...
Seekingalpha · 06/30 12:36
More
Forecast
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AVGR. Analyze the recent business situations of Avinger through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AVGR stock price target is 2.500 with a high estimate of 2.500 and a low estimate of 2.500.
EPS
Institutional Holdings
Institutions: 48
Institutional Holdings: 9.64M
% Owned: 10.11%
Shares Outstanding: 95.35M
TypeInstitutionsShares
Increased
11
5.24M
New
14
401.77K
Decreased
2
614.40K
Sold Out
11
973.04K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.80%
Healthcare Equipment & Supplies
+0.94%
Key Executives
Chairman/Non-Executive Independent Director
James Cullen
President/Chief Executive Officer/Director
Jeffrey Soinski
Chief Financial Officer
Mark Weinswig
Chief Technology Officer
Himanshu Patel
Independent Director
Tamara Elias
Independent Director
James McElwee
No Data
About AVGR
Avinger, Inc., (Avinger) is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with the peripheral arterial disease (PAD). The Company manufactures and sells a suite of products in the United States and select international markets. Avinger’s products include its Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.

Webull offers kinds of Avinger Inc stock information, including NASDAQ:AVGR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVGR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVGR stock methods without spending real money on the virtual paper trading platform.